Trials / Completed
CompletedNCT00010114
Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children
Gene Expression Profiling of Infant Embryonal Central Nervous System Tumors by Microarray Gene Chip Analysis: Angiogenesis, Invasion and Metastasis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 83 (actual)
- Sponsor
- Pediatric Brain Tumor Consortium · Network
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Genetic studies may help in understanding the genetic processes involved in the development of some types of cancer. PURPOSE: Genetic study to learn more about genes involved in the development of central nervous system tumors in young children.
Detailed description
OBJECTIVES: * Identify known genes that have significantly different levels of expression, using microarray gene chip analysis, in infants with newly diagnosed metastatic vs non-metastatic embryonal central nervous system tumors. * Determine the protein expression of genes identified by microarray analysis that are involved in cellular functions that regulate angiogenesis, invasion, or metastasis in this patient population. * Determine the quantity of gene expression of the confirmed translationally expressed genes using semi-quantitative polymerase chain reaction. OUTLINE: This is a multicenter study. Tumor samples are analyzed using microarray gene chip analysis. Differentially expressed genes are evaluated for protein expression by standard immunohistochemistry and/or Western blot analysis, and gene expression is further quantified by semi-quantitative polymerase chain reaction. PROJECTED ACCRUAL: Approximately 80-100 patients (20-25 with metastatic disease and 60-75 with non-metastatic disease) will be accrued for this study within 4-5 years.
Conditions
Timeline
- Start date
- 2001-03-01
- Primary completion
- 2003-03-01
- Completion
- 2003-03-01
- First posted
- 2003-06-06
- Last updated
- 2011-07-20
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00010114. Inclusion in this directory is not an endorsement.